<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02108756</url>
  </required_header>
  <id_info>
    <org_study_id>2014-CTTQ-SPAN</org_study_id>
    <nct_id>NCT02108756</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of L-Pantoprazole Sodium Injection to Treat Upper Gastrointestinal Ulcer Bleeding</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chia Tai Tianqing Pharmaceutical Group Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chia Tai Tianqing Pharmaceutical Group Co., Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and Efficacy of L- Pantoprazole sodium to&#xD;
      treat upper gastrointestinal ulcer bleeding.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hemostatic success rate</measure>
    <time_frame>6 days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">272</enrollment>
  <condition>Bleeding Gastric Ulcer</condition>
  <condition>Bleeding Duodenal Ulcer</condition>
  <arm_group>
    <arm_group_label>L-pantoprazole sodium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Panmeilu</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>L-pantoprazole sodium</intervention_name>
    <description>2 injection L-pantoprazole sodium (40mg), Bid</description>
    <arm_group_label>L-pantoprazole sodium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Panmeilu</intervention_name>
    <description>An injection Panmeilu (80 mg) + 1 branch placebo, Bid;</description>
    <arm_group_label>Panmeilu</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age: 18-65 years, gender:both.&#xD;
&#xD;
          2. Patients whose Forrest classification were in Ⅰ b-Ⅱ c were diagnosed with non-variceal&#xD;
             duodenal and / or gastric ulcer bleeding by endoscopy within 24 hours and patients&#xD;
             manifested vomiting and / or black stools and other symptoms of upper gastrointestinal&#xD;
             bleeding.&#xD;
&#xD;
          3. Patients were diagnosed with upper gastrointestinal bleeding mild to moderate;&#xD;
&#xD;
          4. Informed consent granted.&#xD;
&#xD;
          5. Patients agreed to take medicine and assess.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients were diagnosed with upper gastrointestinal bleeding by endoscopy caused by&#xD;
             esophageal varices and portal hypertensive gastropathy, Mallory-Weiss syndrome,&#xD;
             dieulafoy disease.&#xD;
&#xD;
          2. Pregnant women or breastfeeding women.&#xD;
&#xD;
          3. Patients who had undergone surgery because of ulcer complications or gastrectomy,&#xD;
             gastrointestinal anastomosis within 30 days before the trial.&#xD;
&#xD;
          4. Patients were diagnosed with gastrinoma or gastric malignancy.&#xD;
&#xD;
          5. Patients had other associated complications, which may affect the efficacy.&#xD;
&#xD;
          6. Patients who like alcohol abuse, drug addicts or others which are not suitable for&#xD;
             drug trials.&#xD;
&#xD;
          7. Patients who were allergic to any ingredient of any PPI and allergies.&#xD;
&#xD;
          8. Patients diagnosed with small vessel spurting who had to undergo endoscopic hemostasis&#xD;
             or surgery or severe gastrointestinal bleeding.&#xD;
&#xD;
          9. Patients suffering from serious heart, brain, lung, liver, kidney disease or severe&#xD;
             hypertension.&#xD;
&#xD;
         10. Patients who had coagulopathy, whose PT wasmore three seconds than normal controls,&#xD;
             whose APTT&gt; 1.5 times the upper limit of normal or low-dose heparin treatment.&#xD;
&#xD;
         11. Patients whose systolic blood pressure less than 90mmHg or lower &gt; 30mmHg than the&#xD;
             baseline systolic blood pressure, pulse pressure less than 20mmHg, hematocrit less&#xD;
             than 20%.&#xD;
&#xD;
         12. Patients who participated in other clinical trials within three months before this&#xD;
             trial.&#xD;
&#xD;
         13. Patients who need to use other drugs which may affect the trial during the trial or a&#xD;
             week before the trial.&#xD;
&#xD;
         14. Patients who were considered unsuitable for selected candidates.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Han Ying, doctor</last_name>
    <phone>13991963770</phone>
    <email>hanying@fmmu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>The first affiliated hospital of the Fourth Military Medical University</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Han Ying, doctor</last_name>
      <phone>13991963770</phone>
      <email>hanying@fmmu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Fan Dai ming, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wu Kai chun, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Han Ying, doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <study_first_submitted>April 7, 2014</study_first_submitted>
  <study_first_submitted_qc>April 8, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 9, 2014</study_first_posted>
  <last_update_submitted>April 8, 2014</last_update_submitted>
  <last_update_submitted_qc>April 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Ulcer</mesh_term>
    <mesh_term>Duodenal Ulcer</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pantoprazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

